Aytu BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
February 21, 2023 at 04:36 pm
Aytu BioPharma, Inc. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported net loss was USD 6.69 million compared to USD 11.55 million a year ago. Basic loss per share from continuing operations was USD 2.15 compared to USD 8.74 a year ago.
For the six months, net loss was USD 7.39 million compared to USD 39.4 million a year ago. Basic loss per share from continuing operations was USD 2.62 compared to USD 30.3 a year ago.